Resilience 2026 builds directly on the progress documented in the 2025 conference report. The upcoming conference will further deepen scientific inquiry on Day 1, with a strong emphasis on epidemiology, indoor air quality research, and emerging biological mechanisms. Day 2 will continue to elevate lived experience while advancing policy, legal, and systems-level solutions that translate knowledge into action. Participation in […]
One of the most powerful outcomes of Resilience 2025 was the sense of shared momentum. The conference brought together voices from multiple continents, reflecting parallel trends in prevalence, under-recognition, and environmental risk. The discussions made clear that MCS is not confined to a single country or healthcare system but represents a global challenge requiring coordinated, cross-sectoral responses. The conference report […]
Equally central to Resilience 2025 was the integration of lived experience alongside scientific and legal expertise. Testimonies from individuals living with MCS illustrated the daily realities of navigating healthcare systems, workplaces, housing, and public spaces that often remain inaccessible due to chemical exposures. Policy and legal sessions examined how disability rights frameworks can be strengthened to better protect people with […]
A major focus of Resilience 2025 was strengthening the scientific foundation needed to address MCS as an urgent public health issue. Presentations highlighted emerging research in environmental medicine, public health, indoor air quality, toxicology, and epidemiology, reinforcing the increasing prevalence of MCS, a legitimate and recognized disability. Speakers emphasized the role of cumulative low-level chemical exposures, fragrance use, and poorly […]
In May 2025, Resilience convened researchers, clinicians, policymakers, advocates, and people with lived experience from across Canada and around the world for a landmark international conference on Multiple Chemical Sensitivity (MCS). The Resilience 2025 Conference Report captures a pivotal moment in the global movement toward recognition, evidence-based care, and meaningful inclusion for people affected by Multiple Chemical Sensitivity (MCS) and […]